Press release
20% CAGR growth by 2023 in the Epigenetics | Major Vendors - ABCAM PLC, ACTIVE MOTIFF, DIAGENODE INC, ILLUMINA INC, MERCK & CO., QIAGEN, ROCHE, amongst others
Market Analysis:United States has the Highest Market Share
In North America, the United States is dominating the epigenetics market due to the factors, such as increasing prevalence rate of cancer, increasing funding for the R&D, and the increasing collaborations between several large pharmaceutical companies for development of enhanced therapeutics. Asia-Pacific is expected to record a substantial growth over the forecast period.
Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16806
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”
Epigenetics is defined as the study of changes in gene expression, which are caused by certain base pairs in DNA, or RNA, being turned off or on again, through the chemical reactions. According to Cancer Research UK, in 2012, 14.1 million new cases of cancer were diagnosed worldwide. The World Health Organization estimated that this figure may rise to 35 million new cases in 2035. This depicts the large patient pool of cancer patients, which will propel the growth of the epigenetics market. The other factors, like increasing funding for R&D in healthcare and the rising epigenetic applications in non-oncology diseases, are driving the market. Rising cost of instruments and lack of skilled researchers is restraining the market growth of epigenetics.
Request Discount on this report @ https://marketprognosis.com/discount-request/16806
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”
Market Segments:
Epigenetics Market is segmented by:
1. Kits: Bisulfite Conversion Kits, Chip-seq Kits, RNA Sequencing Market, Whole Genome Amplification Market, 5-HMC and 5-MC Analysis Kits, Other Kits
2. Reagents: Antibodies, Buffers, Histones, Magnetic Beads, Primers, Other Reagents
3. Enzymes: DNA - Modifying Enzymes, Protein Modifying Enzymes, RNA Modifying Enzymes
4. Instruments: Mass Spectrometer, Sonicators, Next Generation Sequencers, Others
5. Application: Oncology, Non-Oncology, Developmental Biology, Other Research Areas
6. Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA modification, Chromatin Structures
7. Geography: North America, South America, Europe, Asia Pacific, Middle East & Africa
Key Developments in the Market
• December 2017: Roche and Ignyta made definitive merger agreement
• December 2017: Zymo Research collaborated with Bertin
Enquiry before Buying @ https://marketprognosis.com/enquiry/16806
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”
About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today's complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.
Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 20% CAGR growth by 2023 in the Epigenetics | Major Vendors - ABCAM PLC, ACTIVE MOTIFF, DIAGENODE INC, ILLUMINA INC, MERCK & CO., QIAGEN, ROCHE, amongst others here
News-ID: 1635962 • Views: …
More Releases from Market Prognosis
Third-Party Logistics (3PL) Market Latest Study Focuses On Current, Future Innov …
The report covers a forecast and an analysis of the Third-Party Logistics (3PL) Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume.
Overview of the Global Third-Party Logistics (3PL) Market:
The report spread across 90 pages is an overview of the Global Third-Party Logistics (3PL) Market. These report study based on the Third-Party…
Ride-Hailing Market: An Insight on the Important Factors and Trends Influencing …
The report covers a forecast and an analysis of the Ride-Hailing Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume.
Overview of the Global Ride-Hailing Market:
The report spread across 90 pages is an overview of the Global Ride-Hailing Market. These report study based on the Ride-Hailing Market. It is a complete overview…
COVID-19 Impact on Professional Indemnity Insurance Market 2021-2026: Industry I …
The report covers a forecast and an analysis of the Professional Indemnity Insurance Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume.
Overview of the Global Professional Indemnity Insurance Market:
The report spread across 90 pages is an overview of the Global Professional Indemnity Insurance Market. These report study based on the Professional…
Modular Construction Market Future Growth Explored in Latest Research Report by …
The report covers a forecast and an analysis of the Modular Construction Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume.
Overview of the Global Modular Construction Market:
The report spread across 90 pages is an overview of the Global Modular Construction Market. These report study based on the Modular Construction Market. It…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
